Ask AI
ARCHES 5 Year OS
ARCHES: Post Hoc Analysis of 5-Yr OS Outcomes for Phase III Trial of Enzalutamide + ADT vs Placebo + ADT in Patients With mHSPC

Released: June 01, 2025

Expiration: November 30, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 01, 2025

Expiration: November 30, 2025